Ernest Chan
@ErnestChanMD
Followers
787
Following
7K
Media
346
Statuses
5K
Urologist, Robotic Surgeon at @LakeridgeHealth. Specializing in prostate and kidney cancer. Alumnus of @THP_hospital and @WesternUUrology. 🇨🇦
Ontario, Canada
Joined August 2010
👀 ⭐️@WaldoGMed @nyphospital @KeithKow @GUUrology 10th @EUplatinum journals Surgery in Motion. Largest comparison of Hood, Retzius vs Std Robotic RP: Retzius>Hood>Std continence recovery, but ⬆️ Retzius + SMs https://t.co/KsFVOmOgeO
1
13
64
From the NEJM Archive: Retropubic Prostatectomy (Original Article, July 8, 1948) https://t.co/1B97ay1TfA
1
7
22
Epidemiologic evidence or claims data baloney? Robotic prostatectomy with a survival advantage over open RRP https://t.co/HyRPf2dgoS
5
4
14
X-torial: Cleaning up the misinformation about @JoeBiden and #ProstateCancer that I am reading everywhere. The purpose of this is to provide education from someone who treats and studies PCa for a living, lead the USA @NCCN PCa guidelines, hold leadership in @NRGonc @theNCI
24
146
355
#AUA25 kicks straight off with a thorny topic: do we really understand localised prostate cancer? Answer: clearly no! We can't even agree on our age-old risk strat criteria: •GG1, PSA 21, 150cc = High risk 🤔 •GG2 49% ≠ GG3 51% 😂 •GG4 2mm 100% 4 worse than GG2 12mm 40% 4🤦
4
17
60
Wow, again showing the power of baseline PSA. Only 9 prostate cancers detected out of 14,000 men with baseline psa <1.5 in 5 years of follow up!Going to need to dissect this further and get into the weeds/nuance.
Editor's Choice: Risk-adjusted Screening for Prostate Cancer—Defining the Low-risk Group by Data from the PROBASE Trial by Agne Krilaviciute et al Read the full article here: https://t.co/SBDKOZRU74 Come back later to read the Editorial! #UroSoMe #MedTwitter #eururol
0
4
13
🚨Neurosafe RCT(n=407) at gamechanger sess by Greg Shaw #EAU25. In men with good baseline erections having RALP, 12 mth erectile function better with neurosafe technique vs SOC (IIEF 12.7vs9.7, p<0.001) & early continence better. Published @TheLancetOncol
https://t.co/gCfwIhCs1N
5
25
62
A patient requests a 2nd opinion because you will not offer intervention X, which you believe is not indicated. You have explained all you can. The issue is not controversial, and you believe that other specialists would also not offer X. In this circumstance, you would:
11
5
14
1. How big is your trocar site incision? Last week we established that a 5mm trocar has an outer diameter of 7.7mm. #surgery @rbarbosa91 @CPark_MD @VNikolian @SAGES_Updates @teachmesurgery @surgicalpizza @MISIRG1 @OMGhanemMD @EmorySurgery @IvyNHaskinsMD
9
74
293
1/4 Delighted to share @WaldoGMed @JoshWinogradMS @mark_farha @WeillCornell @nyphospital @NatRevUrol radical prostatectomy hemostasis technique that enables same day discharge RP and cessation of postop labs https://t.co/GCfysCi5lh
4
7
48
Just out in @bmj_latest, our "Uncertainties in Practice" article on #LATP vs #TRUS We highlight evidence so far, discordance between recommendations (@Uroweb vs @NICEComms vs @AmerUrological) & need for nuance (!) Not long now until @TranslateTrial... https://t.co/vhIKSKMNOl👈
3
23
48
Longer follow-up from our landmark ProPSMA study just out @EurUrolOncol: PSMA nodal status is prognostic! At 3 years 70% of patients without nodal involvement (N0) disease free, vs. only 46% if N1 CT-defined nodal status is not prognostic. Read the details here:
5
49
147
Assessing the Impact of Positive Surgical Margins on Mortality in Patients Who Underwent Robotic Radical Prostatectomy: 20 Years’ Report from the EAU Robotic Urology Section Scientific Working Group by Francesco Pellegrino, @UFalagario et al https://t.co/27ndswHgUW
#UroSoMe
1
12
48
Radical cystectomy (RC) and trimodality therapy (TMT) yield comparable outcomes in muscle-invasive bladder cancer (MIBC)? ✨ 74.4% complete response with TMT. 🔄 23.1% recurrence rate in TMT-treated patients. ⚠️ 11.4% grade ≥3 toxicity for TMT. Does this change your practice?
3
30
84
📣Seminar Alert‼️: The impact of complications on surgeons. Introduction to the seminar on “the impact of complications on surgeons” https://t.co/36KNZclrOj
@eric_facs @marthpodi
1
3
6
Been saying it for years. We need to really stop stressing the importance of the DRE for prostate cancer screening. ➡️It’s a barrier to men coming in for cancer screening. ➡️Data now consistently shows it has little value for prostate cancer screening. ➡️ accordingly the AUA no
Comparing the Performance of Digital Rectal Examination and Prostate-specific Antigen as a Screening Test for Prostate Cancer: A Systematic Review and Meta-analysis - European Urology Oncology
2
12
58
🔵November is #ProstateCancerAwarenessMonth Prostate cancer is a result of changes in the DNA of prostate cells that cause them to grow faster than usual. Urologists diagnose and treat prostate cancer every day. #ProstateCancerAwarenessMonth #PCAM
#Procure
0
1
7
🚨Correlates between PSMA PET and MRI for clinically significant #ProstateCancer 🚨 Our group just published in @JournalofNucMed 👉 132 tumors GG>2 from 100 pts who got both PET and MRI prior to prostatectomy @UCLAHealth 🗣️📢PET detects more tumors compared to MRI by:
4
49
126